Close Menu

NEW YORK – Luminex reported after the close of the market on Monday that its fourth quarter revenues rose 23 percent year over year, in line with preliminary estimates announced in January.

For the three months ended Dec. 31, 2020, the Austin, Texas-based diagnostics company reported revenues of $111.4 million compared to $90.5 million in Q4 2020, and beating analysts' average estimate for revenues of $104.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.